Atezolizumab/Carboplatin/Etoposide Followed by Atezolizumab/Lurbinectedin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of atezolizumab, carboplatin and etoposide followed by atezolizumab and lurbinectedin that can be used in the treatment of small cell lung cancer (SCLC).

**Synonyms:** - Atezolizumab-Carboplatin-Etoposide Followed by Atezolizumab-Lurbinectedin - Atezolizumab/Carboplatin/Etoposide Followed by Atezolizumab/Lurbinectedin - Carboplatin/Etoposide Plus Atezolizumab Followed by Atezolizumab Plus Lurbinectedin - Carboplatin/Etoposide Plus Atezolizumab Followed by Lurbinectedin Plus Atezolizumab - Tecentriq/Paraplatin/VePesid Followed by Tecentriq/Zepzelca